相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening
Nicolas Wentzensen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Next-Generation Analytics for Omics Data
Jun Li et al.
CANCER CELL (2021)
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
Luis Paz-Ares et al.
LANCET ONCOLOGY (2021)
Identification of New Hsp90 Inhibitors: Structure Based Virtual Screening, Molecular Dynamic Simulation, Synthesis and Biological Evaluation
Maryam Abbasi et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial
Istvan Petak et al.
NPJ PRECISION ONCOLOGY (2021)
Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review
Houssein Safa et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Systemic immunity in cancer
Kamir J. Hiam-Galvez et al.
NATURE REVIEWS CANCER (2021)
Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer
Youngtae Jeong et al.
CLINICAL CANCER RESEARCH (2020)
New insight in endocrine-related adverse events associated to immune checkpoint blockade
Giusy Elia et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation
Ichidai Tanaka et al.
CLINICAL LUNG CANCER (2020)
UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis
Su Guan et al.
JOURNAL OF PROTEOME RESEARCH (2020)
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
Sylvie Lantuejoul et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
The evolutionary history of 2,658 cancers
Moritz Gerstung et al.
NATURE (2020)
External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules
David R. Baldwin et al.
THORAX (2020)
Pathway and network analysis of more than 2500 whole cancer genomes
Matthew A. Reyna et al.
NATURE COMMUNICATIONS (2020)
Integrative pathway enrichment analysis of multivariate omics data
Marta Paczkowska et al.
NATURE COMMUNICATIONS (2020)
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Maria Escala-Garcia et al.
NATURE COMMUNICATIONS (2020)
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma
Khalid AbdulJabbar et al.
NATURE MEDICINE (2020)
New immunotherapeutic drugs in advanced non-small cell lung cancer (NSCLC): from preclinical to phase I clinical trials
Danilo Rocco et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Targeting Immunometabolism Mediated by CD73 Pathway inEGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance
Anna Passarelli et al.
FRONTIERS IN IMMUNOLOGY (2020)
Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients
Hamada A. A. Noreldeen et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2020)
Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model
Michael T. Lu et al.
ANNALS OF INTERNAL MEDICINE (2020)
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
Michael S. Binkley et al.
CANCER DISCOVERY (2020)
Artificial Intelligence (AI)-Based Systems Biology Approaches in Multi-Omics Data Analysis of Cancer
Nupur Biswas et al.
FRONTIERS IN ONCOLOGY (2020)
A genomic signature for accurate classification and prediction of clinical outcomes in cancer patients treated with immune checkpoint blockade immunotherapy
Mei Lu et al.
SCIENTIFIC REPORTS (2020)
Machine learning reveals a PD-L1-independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context
Marcel Wiesweg et al.
EUROPEAN JOURNAL OF CANCER (2020)
A census of pathway maps in cancer systems biology
Brent M. Kuenzi et al.
NATURE REVIEWS CANCER (2020)
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
Valsamo Anagnostou et al.
NATURE CANCER (2020)
Optimal deep learning model for classification of lung cancer on CT images
S. K. Lakshmanaprabu et al.
FUTURE GENERATION COMPUTER SYSTEMS-THE INTERNATIONAL JOURNAL OF ESCIENCE (2019)
RNA sequencing and swarm intelligence-enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA
Myron G. Best et al.
NATURE PROTOCOLS (2019)
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV
Hiroaki Akamatsu et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Tony S. K. Mok et al.
LANCET (2019)
End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography
Diego Ardila et al.
NATURE MEDICINE (2019)
Machine Learning in Medicine
Alvin Rajkomar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
Caicun Zhou et al.
LANCET RESPIRATORY MEDICINE (2019)
Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
Alessandro Leonetti et al.
BRITISH JOURNAL OF CANCER (2019)
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Artificial Intelligence for Clinical Trial Design
Stefan Harrer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Automated acquisition of explainable knowledge from unannotated histopathology images
Yoichiro Yamamoto et al.
NATURE COMMUNICATIONS (2019)
An analysis of genetic heterogeneity in untreated cancers
Johannes G. Reiter et al.
NATURE REVIEWS CANCER (2019)
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Ferdinandos Skoulidis et al.
NATURE REVIEWS CANCER (2019)
Pathologist-level interpretable whole-slide cancer diagnosis with deep learning
Zizhao Zhang et al.
NATURE MACHINE INTELLIGENCE (2019)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell et al.
SCIENCE (2018)
NRF2 and the Hallmarks of Cancer
Montserrat Rojo de la Vega et al.
CANCER CELL (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Katherine A. Hoadley et al.
CELL (2018)
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
Jianfeng Shen et al.
NATURE MEDICINE (2018)
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dal Fukurnura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Methodologic Guide for Evaluating Clinical Performance and Effect of Artificial Intelligence Technology for Medical Diagnosis and Prediction
Seong Ho Park et al.
RADIOLOGY (2018)
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis et al.
CANCER DISCOVERY (2018)
Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins
Florence Guida et al.
JAMA ONCOLOGY (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations (vol 173, 371.e1, 2018)
Matthew H. Bailey et al.
CELL (2018)
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao et al.
NATURE GENETICS (2018)
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning
Nicolas Coudray et al.
NATURE MEDICINE (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study
Ahmed Hosny et al.
PLOS MEDICINE (2018)
Artificial intelligence in radiology
Ahmed Hosny et al.
NATURE REVIEWS CANCER (2018)
Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
Kathryn C. Arbour et al.
CLINICAL CANCER RESEARCH (2018)
Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy
Lizza E. Hendriks et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma
Muge Celiktas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma
Muge Celiktas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
Babak Ehteshami Bejnordi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Nasser Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
Jiyeon Kim et al.
NATURE (2017)
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer
Solange Peters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Machine Learning of Three-dimensional Right Ventricular Motion Enables Outcome Prediction in Pulmonary Hypertension: A Cardiac MR Imaging Study
Timothy J. W. Dawes et al.
RADIOLOGY (2017)
Deep Learning at Chest Radiography: Automated Classification of Pulmonary Tuberculosis by Using Convolutional Neural Networks
Paras Lakhani et al.
RADIOLOGY (2017)
Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody Therapy
Fernando Concha-Benavente et al.
FRONTIERS IN PHARMACOLOGY (2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan et al.
CELL (2017)
Unravelling biology and shifting paradigms in cancer with single-cell sequencing
Timour Baslan et al.
NATURE REVIEWS CANCER (2017)
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets
Myron G. Best et al.
CANCER CELL (2017)
Computer-aided detection (CADe) and diagnosis (CADx) system for lung cancer with likelihood of malignancy
Macedo Firmino et al.
BIOMEDICAL ENGINEERING ONLINE (2016)
STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment
Shohei Koyama et al.
CANCER RESEARCH (2016)
Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening
Falco Kilchmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A multi-layer omics approach to cancer
Denise Waldron
NATURE REVIEWS GENETICS (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
Cyrille J. Cohen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Benjamin J. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Circulating Pro-Surfactant Protein B as a Risk Biomarker for Lung Cancer
Ayumu Taguchi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Pro-Surfactant Protein B As a Biomarker for Lung Cancer Prediction
Don D. Sin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Lung Cancer Screening With Low-Dose Computed Tomography: Costs, National Expenditures, and Cost-Effectiveness
Bernardo H. L. Goulart et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models
Ayumu Taguchi et al.
CANCER CELL (2011)
CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant
Hiroshi Sakamoto et al.
CANCER CELL (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond
Sai-Hong Ignatius Ou
DRUG DESIGN DEVELOPMENT AND THERAPY (2011)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
LKB1 modulates lung cancer differentiation and metastasis
Hongbin Ji et al.
NATURE (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome
Nicholas Hearle et al.
CLINICAL CANCER RESEARCH (2006)
分享论文
